Cancer Screening

Essential Biomarker Screening for Early Health Assessment Cancer screening is an important component of preventive healthcare, helping physicians identify potential abnormalities and determine whether further investigation may be appropriate. PINN Wellnessology offers a blood and stool-based screening panel incorporating selected tumor markers according to sex. The Male Cancer Screening panel includes CA 19-9, CEA, AFP, PSA, and Stool Examination. These markers may provide supportive information related to the prostate, liver, gastrointestinal tract, pancreas, and other relevant systems. The Female Cancer Screening panel includes CA 19-9, CEA, AFP, CA 15-3, CA 125, and Stool Examination, providing a broader assessment that also incorporates markers commonly associated with breast and ovarian health. Tumor markers are substances that may be produced by cancer cells or by the body in response to certain conditions. However, an abnormal tumor marker result does not by itself diagnose cancer, and normal results cannot completely exclude it. Some markers may also be elevated in non-cancerous conditions. For this reason, results should always be interpreted by a physician together with personal and family history, symptoms, physical examination, and other appropriate investigations. Regular health screening supports a proactive approach to long-term wellbeing and allows individualized follow-up when clinically indicated.